Mepolizumab Following Hospitalisation for Severe Exacerbation of Eosinophilic COPD

Category Primary study
ConferenceEuropean Respiratory Society Congress, ERS 2025
Year 2025
This article has no abstract
Epistemonikos ID: 806d71e3bd301303c2dff1e9c78cbbb7c4a7a3d8
First added on: Apr 18, 2026